You have reached an outdated page.
Please visit the Defeat Diabetes Foundation's new Web site at:
http://www.DefeatDiabetes.org
Defeat Diabetes: Long-Term Pharmacotherapy for Obesity Brings Small Overall Weight Loss

Long-Term Pharmacotherapy for Obesity Brings Small Overall Weight Loss
posted 04/09/03

Orlistat or sibutramines effectiveness over time averages less then 5% weight loss

Long-term treatment with orlistat or sibutramine results in weight loss averaging less than 5% of body weight, according to research presented at the 2003 Annual Meeting of the Society for Clinical Pharmacology and Therapeutics.

Dr. Raj Padwal from University of Toronto, Ontario, Canada and colleagues undertook a systematic review to examine the effectiveness and safety of orlistat and sibutramine for long-term promotion of weight loss.

In 8 controlled trials lasting 12 months or more, orlistat produced a mean incremental weight loss (compared with placebo) of 2.7 kg, the investigators report, or 2.9% of the initial body weight.

Similarly, in 3 controlled trials, sibutramine provided a 4.3-kg (or 4.6% of baseline body weight) greater weight loss than did placebo after a year of treatment.

With both drugs, the percentage of patients achieving < 10% better weight loss than achieved with placebo was small, the researchers indicate--3% with orlistat and 15% with sibutramine.

High attrition rates (33% in the orlistat studies and 48% in the sibutramine studies) hampered the study quality for both agents, the results indicate.

Dr. Padwal stated that GI side effects were more common with orlistat treatment, whereas sibutramine use was associated with small but significant increases in systolic blood pressure (mean increase, 0.8 mm Hg) and diastolic blood pressure (2.2 mm Hg). "This is of special concern," he said, "because we would expect blood pressure to fall with weight loss and because increased blood pressure is what you would hope to avoid as another cardiovascular risk factor."

Dr. Padwal said that, given the choice, "I would favor orlistat over sibutramine because of the side effect profiles. But neither treatment provides impressive weight loss."

Source: Diabetes In Control Dot Com.

April News Article Index

 

Home - Table of Contents - Donate Now - About Diabetes - Warning Signs - Complications - Screening Test - Diabetes Terms - Site Search - Meet Mr. Diabetes®  -  Wake Up And Walk® Tour - Latest News - Headlines & News Stories - Health & Fitness - About Us - FAQ - Research Form - Message Board - Privacy Policy - Legal Notices - How to Contact Us - Comments form - Suggestion Form - Our E-Mail Addresses - Our Address and Phone Numbers - Links - Contact Us